Related Experiment Video
Updated: May 9, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Sevoflurane therapy for life-threatening asthma in children
D Schutte1, A M Zwitserloot, R Houmes
1Department of Intensive Care Medicine and.
Insights
Sevoflurane inhalation therapy effectively treated severe asthma in mechanically ventilated children. This treatment improved carbon dioxide levels and clinical status in pediatric intensive care unit patients.
Area of Science:
- Pediatric critical care medicine
- Respiratory medicine
- Pharmacology
Background:
- Asthma is a prevalent childhood respiratory condition with early onset.
- Severe asthma exacerbations in children necessitate intensive care.
- This study investigates sevoflurane inhalation therapy for severe pediatric asthma.
Purpose of the Study:
- To evaluate the effectiveness of sevoflurane inhalation therapy.
- To assess clinical outcomes in children with severe asthma requiring mechanical ventilation.
- To explore sevoflurane's role in refractory pediatric asthma cases.
Main Methods:
- A multicentre retrospective case series.
- Inclusion of seven children (4-13 years) with severe asthma in the pediatric intensive care unit (PICU).
- Treatment involved sevoflurane inhalation therapy during invasive mechanical ventilation.
Main Results:
- Sevoflurane inhalation significantly reduced carbon dioxide levels (Pco2) and normalized pH.
- Peak airway pressures decreased, indicating improved lung mechanics.
- Hypotension was the main adverse effect, responsive to norepinephrine.
Conclusions:
- Sevoflurane inhalation therapy is effective in correcting hypercapnia in mechanically ventilated children with severe asthma.
- It provides clinical improvement for life-threatening asthma cases unresponsive to standard treatments.
- Sevoflurane represents a viable therapeutic option for severe pediatric asthma.
Background:
Asthma is a common disease in children and often develops early in life. This multicentre retrospective case series describe the use and effectiveness of sevoflurane inhalation therapy in a series of children with severe asthma in the paediatric intensive care unit (PICU).
Methods:
Seven children ranging from 4 to 13 yr of age admitted to the PICU of two tertiary care hospitals in the Netherlands were included. They all were admitted with the diagnosis of severe asthma requiring invasive mechanical ventilation and were treated with sevoflurane inhalation therapy.
Results:
The median (range) Pco2 level at the start, after 2 h, and at the end of sevoflurane treatment were 14 (5.1-24.8), 9.8 (5.4-17.0), and 6.2 (4.5-11.4) kPa (P=0.05) while the median (range) pH was 7.02 (6.97-7.36), 7.18 (7.04-7.35), and 7.43 (7.15-7.47) kPa (P=0.01), respectively. The median (range) peak pressure values declined from 30 (23-56) to 20.4 (14-33) cm H2O (P=0.03). No severe adverse effects besides hypotension, with sufficient response to norepinephrine treatment, were seen.
Conclusions:
Sevoflurane inhalation corrects high levels of Pco2 and provides clinical improvement in mechanically ventilated children with life-threatening asthma who fail to respond to conventional treatment.
Related Concept Videos
Inhalational Anesthetics: Overview
Asthma-IV: Nursing Management
First, in...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
